| 摘要 |
PURPOSE: A pharmaceutical composition containing asarone is provided to prevent or relieve diabetes. CONSTITUTION: A pharmaceutical composition for preventing or treating diabetes contains 0.01-50 weight% of asarone as an active ingredient. The pharmaceutical composition further contains a carrier, excipient, and diluent. The pharmaceutical composition is manufactured in the form of powder, granule, tablet, capsule, suspension, emulsion, syrup, aerosol, external use formulation, suppository, and sterilized injection solution. An inhibitor of C/EBP alpha and PPAR gamma contains asarone as an active ingredient. A health food for preventing or relieving diabetes contains asarone as an active ingredient. |
